| DM (n = 470) . | PM (n = 217) . | IBM (n = 375) . | ASS (n = 103) . | IMNM (n = 96) . | OM (n = 239) . | |
|---|---|---|---|---|---|---|
| Age, median (IQR), years | 58 (48–67) | 64 (50–70) | 71 (65–76) | 52 (42–63) | 57 (49–66) | 49 (40–60) |
| Gender, n (%) | ||||||
| Male | 84 (17.9) | 54 (24.9) | 221 (58.9) | 16 (15.5) | 27 (28.1) | 18 (7.5) |
| Female | 383 (81.5) | 161 (74.2) | 152 (40.5) | 85 (82.5) | 69 (71.9) | 213 (89.1) |
| Do not wish to disclose | 1 (0.2) | 1 (0.4) | 2 (0.5) | 1 (0.2) | 0 (0) | 1 (0.4) |
| Others | 1 (0.2) | 1 (0.4) | 0 (0) | 0 (0) | 0 (0) | 1 (0.4) |
| Ethnicity, n (%) | ||||||
| Caucasian (White) | 378 (80.4) | 171 (78.8) | 349 (93.1) | 81 (78.6) | 74 (77.1) | 120 (50.2) |
| Asian | 24 (5.1) | 13 (6) | 6 (1.6) | 9 (8.7) | 7 (7.3) | 58 (24.3) |
| African American | 20 (4.3) | 13 (6) | 4 (1.1) | 2 (1.9) | 6 (6.3) | 13 (5.4) |
| Hispanic | 31 (6.6) | 5 (2.3) | 9 (2.4) | 3 (2.9) | 7 (7.3) | 8 (3.3) |
| Mixed | 10 (2.1) | 5 (2.3) | 0 (0) | 4 (3.9) | 1 (1) | 9 (3.8) |
| Native American | 0 (0) | 0 (0) | 1 (0.3) | 0 (0) | 0 (0) | 2 (0.8) |
| Do not wish to disclose | 6 (1.3) | 4 (1.8) | 5 (1.3) | 0 (0) | 1 (1) | 13 (5.4) |
| Others | 0 (0) | 4 (1.8) | 5 (1.3) | 0 (0) | 1 (1) | 13 (5.4) |
| HDI, n (%) | ||||||
| Very high | 453 (96.4) | 202 (93.1) | 370 (98.7) | 100 (97.1) | 93 (96.9) | 187 (78.2) |
| High | 12 (2.6) | 7 (3.2) | 4 (1.1) | 2 (1.9) | 3 (3.1) | 35 (14.6) |
| Medium | 4 (0.9) | 5 (2.3) | 1 (0.3) | 0 (0) | 0 (0) | 6 (2.5) |
| Low | 0 (0) | 1 (0.5) | 0 (0) | 0 (0) | 0 (0) | 5 (2.1) |
| Disease activity, n (%) | ||||||
| Inactive | 328 (88.2) | 137 (82.5) | 142 (49) | 64 (81) | 50 (72.5) | 125 (86.8) |
| Active | 44 (11.8) | 29 (17.5) | 148 (51) | 15 (19) | 19 (27.5) | 19 (13.2) |
| Comorbidities overall, n (%) | 285 (60.6) | 174 (80.2) | 269 (71.7) | 83 (80.6) | 66 (68.6) | 133 (55.6) |
| OR (95% CI) | 0.7 (0.54, 0.89) | 2.19 (1.21, 3.19) | ns | 2.57 (1.53, 4.34) | ns | ns |
| Basic multimorbidity, n (%) | 127 (27) | 100 (46.1) | 153 (40.8) | 40 (38.8) | 43 (44.8) | 65 (27.2) |
| OR (95% CI) | 0.64 (0.5, 0.82) | 1.68 (1.24, 2.29) | 0.73 (0.54, 0.97) | 1.56 (1.01, 2.42) | 1.72 (1.12, 2.67) | ns |
| Complex multimorbidity, n (%) | 50 (10.6) | 39 (18) | 44 (11.7) | 16 (15.5) | 23 (24) | 35 (14.6) |
| OR (95% CI) | 0.6 (0.42, 0.85) | ns | ns | ns | 2.05 (1.23, 3.39) | ns |
| Mental health disorders, n (%) | 166 (35.3) | 76 (35) | 105 (28) | 31 (30.1) | 34 (35.4) | 94 (39.3) |
| OR (95% CI) | ns | ns | ns | 0.61 (0.38, 0.96) | ns | ns |
| DM (n = 470) . | PM (n = 217) . | IBM (n = 375) . | ASS (n = 103) . | IMNM (n = 96) . | OM (n = 239) . | |
|---|---|---|---|---|---|---|
| Age, median (IQR), years | 58 (48–67) | 64 (50–70) | 71 (65–76) | 52 (42–63) | 57 (49–66) | 49 (40–60) |
| Gender, n (%) | ||||||
| Male | 84 (17.9) | 54 (24.9) | 221 (58.9) | 16 (15.5) | 27 (28.1) | 18 (7.5) |
| Female | 383 (81.5) | 161 (74.2) | 152 (40.5) | 85 (82.5) | 69 (71.9) | 213 (89.1) |
| Do not wish to disclose | 1 (0.2) | 1 (0.4) | 2 (0.5) | 1 (0.2) | 0 (0) | 1 (0.4) |
| Others | 1 (0.2) | 1 (0.4) | 0 (0) | 0 (0) | 0 (0) | 1 (0.4) |
| Ethnicity, n (%) | ||||||
| Caucasian (White) | 378 (80.4) | 171 (78.8) | 349 (93.1) | 81 (78.6) | 74 (77.1) | 120 (50.2) |
| Asian | 24 (5.1) | 13 (6) | 6 (1.6) | 9 (8.7) | 7 (7.3) | 58 (24.3) |
| African American | 20 (4.3) | 13 (6) | 4 (1.1) | 2 (1.9) | 6 (6.3) | 13 (5.4) |
| Hispanic | 31 (6.6) | 5 (2.3) | 9 (2.4) | 3 (2.9) | 7 (7.3) | 8 (3.3) |
| Mixed | 10 (2.1) | 5 (2.3) | 0 (0) | 4 (3.9) | 1 (1) | 9 (3.8) |
| Native American | 0 (0) | 0 (0) | 1 (0.3) | 0 (0) | 0 (0) | 2 (0.8) |
| Do not wish to disclose | 6 (1.3) | 4 (1.8) | 5 (1.3) | 0 (0) | 1 (1) | 13 (5.4) |
| Others | 0 (0) | 4 (1.8) | 5 (1.3) | 0 (0) | 1 (1) | 13 (5.4) |
| HDI, n (%) | ||||||
| Very high | 453 (96.4) | 202 (93.1) | 370 (98.7) | 100 (97.1) | 93 (96.9) | 187 (78.2) |
| High | 12 (2.6) | 7 (3.2) | 4 (1.1) | 2 (1.9) | 3 (3.1) | 35 (14.6) |
| Medium | 4 (0.9) | 5 (2.3) | 1 (0.3) | 0 (0) | 0 (0) | 6 (2.5) |
| Low | 0 (0) | 1 (0.5) | 0 (0) | 0 (0) | 0 (0) | 5 (2.1) |
| Disease activity, n (%) | ||||||
| Inactive | 328 (88.2) | 137 (82.5) | 142 (49) | 64 (81) | 50 (72.5) | 125 (86.8) |
| Active | 44 (11.8) | 29 (17.5) | 148 (51) | 15 (19) | 19 (27.5) | 19 (13.2) |
| Comorbidities overall, n (%) | 285 (60.6) | 174 (80.2) | 269 (71.7) | 83 (80.6) | 66 (68.6) | 133 (55.6) |
| OR (95% CI) | 0.7 (0.54, 0.89) | 2.19 (1.21, 3.19) | ns | 2.57 (1.53, 4.34) | ns | ns |
| Basic multimorbidity, n (%) | 127 (27) | 100 (46.1) | 153 (40.8) | 40 (38.8) | 43 (44.8) | 65 (27.2) |
| OR (95% CI) | 0.64 (0.5, 0.82) | 1.68 (1.24, 2.29) | 0.73 (0.54, 0.97) | 1.56 (1.01, 2.42) | 1.72 (1.12, 2.67) | ns |
| Complex multimorbidity, n (%) | 50 (10.6) | 39 (18) | 44 (11.7) | 16 (15.5) | 23 (24) | 35 (14.6) |
| OR (95% CI) | 0.6 (0.42, 0.85) | ns | ns | ns | 2.05 (1.23, 3.39) | ns |
| Mental health disorders, n (%) | 166 (35.3) | 76 (35) | 105 (28) | 31 (30.1) | 34 (35.4) | 94 (39.3) |
| OR (95% CI) | ns | ns | ns | 0.61 (0.38, 0.96) | ns | ns |
Logistic analysis (bold) adjusted for age, gender, ethnicity, HDI value is reported as OR (95% CI). ASS: antisynthetase syndrome; DM: dermatomyositis; HDI: Human Development Index; IBM: inclusion body myositis; IMNM: immune mediated necrotizing myopathy; ns: not significantly different from other idhiopatic inflammatory myopathies; OM: overlap myositis; PM: polymyositis; OR: odds ratio.
| DM (n = 470) . | PM (n = 217) . | IBM (n = 375) . | ASS (n = 103) . | IMNM (n = 96) . | OM (n = 239) . | |
|---|---|---|---|---|---|---|
| Age, median (IQR), years | 58 (48–67) | 64 (50–70) | 71 (65–76) | 52 (42–63) | 57 (49–66) | 49 (40–60) |
| Gender, n (%) | ||||||
| Male | 84 (17.9) | 54 (24.9) | 221 (58.9) | 16 (15.5) | 27 (28.1) | 18 (7.5) |
| Female | 383 (81.5) | 161 (74.2) | 152 (40.5) | 85 (82.5) | 69 (71.9) | 213 (89.1) |
| Do not wish to disclose | 1 (0.2) | 1 (0.4) | 2 (0.5) | 1 (0.2) | 0 (0) | 1 (0.4) |
| Others | 1 (0.2) | 1 (0.4) | 0 (0) | 0 (0) | 0 (0) | 1 (0.4) |
| Ethnicity, n (%) | ||||||
| Caucasian (White) | 378 (80.4) | 171 (78.8) | 349 (93.1) | 81 (78.6) | 74 (77.1) | 120 (50.2) |
| Asian | 24 (5.1) | 13 (6) | 6 (1.6) | 9 (8.7) | 7 (7.3) | 58 (24.3) |
| African American | 20 (4.3) | 13 (6) | 4 (1.1) | 2 (1.9) | 6 (6.3) | 13 (5.4) |
| Hispanic | 31 (6.6) | 5 (2.3) | 9 (2.4) | 3 (2.9) | 7 (7.3) | 8 (3.3) |
| Mixed | 10 (2.1) | 5 (2.3) | 0 (0) | 4 (3.9) | 1 (1) | 9 (3.8) |
| Native American | 0 (0) | 0 (0) | 1 (0.3) | 0 (0) | 0 (0) | 2 (0.8) |
| Do not wish to disclose | 6 (1.3) | 4 (1.8) | 5 (1.3) | 0 (0) | 1 (1) | 13 (5.4) |
| Others | 0 (0) | 4 (1.8) | 5 (1.3) | 0 (0) | 1 (1) | 13 (5.4) |
| HDI, n (%) | ||||||
| Very high | 453 (96.4) | 202 (93.1) | 370 (98.7) | 100 (97.1) | 93 (96.9) | 187 (78.2) |
| High | 12 (2.6) | 7 (3.2) | 4 (1.1) | 2 (1.9) | 3 (3.1) | 35 (14.6) |
| Medium | 4 (0.9) | 5 (2.3) | 1 (0.3) | 0 (0) | 0 (0) | 6 (2.5) |
| Low | 0 (0) | 1 (0.5) | 0 (0) | 0 (0) | 0 (0) | 5 (2.1) |
| Disease activity, n (%) | ||||||
| Inactive | 328 (88.2) | 137 (82.5) | 142 (49) | 64 (81) | 50 (72.5) | 125 (86.8) |
| Active | 44 (11.8) | 29 (17.5) | 148 (51) | 15 (19) | 19 (27.5) | 19 (13.2) |
| Comorbidities overall, n (%) | 285 (60.6) | 174 (80.2) | 269 (71.7) | 83 (80.6) | 66 (68.6) | 133 (55.6) |
| OR (95% CI) | 0.7 (0.54, 0.89) | 2.19 (1.21, 3.19) | ns | 2.57 (1.53, 4.34) | ns | ns |
| Basic multimorbidity, n (%) | 127 (27) | 100 (46.1) | 153 (40.8) | 40 (38.8) | 43 (44.8) | 65 (27.2) |
| OR (95% CI) | 0.64 (0.5, 0.82) | 1.68 (1.24, 2.29) | 0.73 (0.54, 0.97) | 1.56 (1.01, 2.42) | 1.72 (1.12, 2.67) | ns |
| Complex multimorbidity, n (%) | 50 (10.6) | 39 (18) | 44 (11.7) | 16 (15.5) | 23 (24) | 35 (14.6) |
| OR (95% CI) | 0.6 (0.42, 0.85) | ns | ns | ns | 2.05 (1.23, 3.39) | ns |
| Mental health disorders, n (%) | 166 (35.3) | 76 (35) | 105 (28) | 31 (30.1) | 34 (35.4) | 94 (39.3) |
| OR (95% CI) | ns | ns | ns | 0.61 (0.38, 0.96) | ns | ns |
| DM (n = 470) . | PM (n = 217) . | IBM (n = 375) . | ASS (n = 103) . | IMNM (n = 96) . | OM (n = 239) . | |
|---|---|---|---|---|---|---|
| Age, median (IQR), years | 58 (48–67) | 64 (50–70) | 71 (65–76) | 52 (42–63) | 57 (49–66) | 49 (40–60) |
| Gender, n (%) | ||||||
| Male | 84 (17.9) | 54 (24.9) | 221 (58.9) | 16 (15.5) | 27 (28.1) | 18 (7.5) |
| Female | 383 (81.5) | 161 (74.2) | 152 (40.5) | 85 (82.5) | 69 (71.9) | 213 (89.1) |
| Do not wish to disclose | 1 (0.2) | 1 (0.4) | 2 (0.5) | 1 (0.2) | 0 (0) | 1 (0.4) |
| Others | 1 (0.2) | 1 (0.4) | 0 (0) | 0 (0) | 0 (0) | 1 (0.4) |
| Ethnicity, n (%) | ||||||
| Caucasian (White) | 378 (80.4) | 171 (78.8) | 349 (93.1) | 81 (78.6) | 74 (77.1) | 120 (50.2) |
| Asian | 24 (5.1) | 13 (6) | 6 (1.6) | 9 (8.7) | 7 (7.3) | 58 (24.3) |
| African American | 20 (4.3) | 13 (6) | 4 (1.1) | 2 (1.9) | 6 (6.3) | 13 (5.4) |
| Hispanic | 31 (6.6) | 5 (2.3) | 9 (2.4) | 3 (2.9) | 7 (7.3) | 8 (3.3) |
| Mixed | 10 (2.1) | 5 (2.3) | 0 (0) | 4 (3.9) | 1 (1) | 9 (3.8) |
| Native American | 0 (0) | 0 (0) | 1 (0.3) | 0 (0) | 0 (0) | 2 (0.8) |
| Do not wish to disclose | 6 (1.3) | 4 (1.8) | 5 (1.3) | 0 (0) | 1 (1) | 13 (5.4) |
| Others | 0 (0) | 4 (1.8) | 5 (1.3) | 0 (0) | 1 (1) | 13 (5.4) |
| HDI, n (%) | ||||||
| Very high | 453 (96.4) | 202 (93.1) | 370 (98.7) | 100 (97.1) | 93 (96.9) | 187 (78.2) |
| High | 12 (2.6) | 7 (3.2) | 4 (1.1) | 2 (1.9) | 3 (3.1) | 35 (14.6) |
| Medium | 4 (0.9) | 5 (2.3) | 1 (0.3) | 0 (0) | 0 (0) | 6 (2.5) |
| Low | 0 (0) | 1 (0.5) | 0 (0) | 0 (0) | 0 (0) | 5 (2.1) |
| Disease activity, n (%) | ||||||
| Inactive | 328 (88.2) | 137 (82.5) | 142 (49) | 64 (81) | 50 (72.5) | 125 (86.8) |
| Active | 44 (11.8) | 29 (17.5) | 148 (51) | 15 (19) | 19 (27.5) | 19 (13.2) |
| Comorbidities overall, n (%) | 285 (60.6) | 174 (80.2) | 269 (71.7) | 83 (80.6) | 66 (68.6) | 133 (55.6) |
| OR (95% CI) | 0.7 (0.54, 0.89) | 2.19 (1.21, 3.19) | ns | 2.57 (1.53, 4.34) | ns | ns |
| Basic multimorbidity, n (%) | 127 (27) | 100 (46.1) | 153 (40.8) | 40 (38.8) | 43 (44.8) | 65 (27.2) |
| OR (95% CI) | 0.64 (0.5, 0.82) | 1.68 (1.24, 2.29) | 0.73 (0.54, 0.97) | 1.56 (1.01, 2.42) | 1.72 (1.12, 2.67) | ns |
| Complex multimorbidity, n (%) | 50 (10.6) | 39 (18) | 44 (11.7) | 16 (15.5) | 23 (24) | 35 (14.6) |
| OR (95% CI) | 0.6 (0.42, 0.85) | ns | ns | ns | 2.05 (1.23, 3.39) | ns |
| Mental health disorders, n (%) | 166 (35.3) | 76 (35) | 105 (28) | 31 (30.1) | 34 (35.4) | 94 (39.3) |
| OR (95% CI) | ns | ns | ns | 0.61 (0.38, 0.96) | ns | ns |
Logistic analysis (bold) adjusted for age, gender, ethnicity, HDI value is reported as OR (95% CI). ASS: antisynthetase syndrome; DM: dermatomyositis; HDI: Human Development Index; IBM: inclusion body myositis; IMNM: immune mediated necrotizing myopathy; ns: not significantly different from other idhiopatic inflammatory myopathies; OM: overlap myositis; PM: polymyositis; OR: odds ratio.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
